Treatment Action Group

A double blow: Private-sector funding for TB research drops sharply amid severe public-sector budget cuts

As threat of drug-resistance grows, Big Pharma decreases investments in TB research by 22 percent.

Read More →

TAG symposium: Cascades: Improving TB Care

2013 International Union Against TB and Lung Disease World Conference
Date: 1 November 2013
Time: 18h00 - 22h00
Location: Hôtel Concorde La Fayette, Batignolles/Longchamp Room, 3, Place du Général Koenig, 75850 Paris Cedex 17

Read More →

First-ever targeted roadmap outlines steps to end childhood TB deaths

Cost to end deaths from childhood TB estimated to be at least US$120 million annually.

Read More →

Childhood TB Roadmap to be launched on 1 October in Washington, DC

The World Health Organization, The Union, the Stop TB Partnership, USAID, CDC, the Treatment Action Group and UNICEF will launch a roadmap outlining the path towards zero deaths from childhood tuberculosis.

Read More →

TAG, TB CAB open letter to Alere

Re: Responsible marketing and access plans for Alere’s Determine TB-­LAM antigen test for active TB

Read More →

Treatment Action Group criticizes European refusal of new drug to fight tuberculosis

Approval of and access to delamanid is crucial while further research is pending.

Read More →

TAG, TB CAB open letter to Sequella

Re: Further research into sutezolid urgently needed for tuberculosis

Read More →

TAG, TB CAB, India CAB open letter to Immunoshop

Re: Marketing and use of TB Platinum for active TB in India and high TB burden countries

Read More →

Open letter to Sanofi: Reduce rifapentine cost and increase research funding

Leading doctors, advocacy groups, medical organizations and U.S. TB programs call upon Sanofi to lower the price of rifapentine to ensure its accessibility and continue and expand its investments in the development of the drug for active TB.

Read More →

HIV i-Base/TAG: 2013 Pipeline Report

Survey shows HIV pipeline healthy, HCV drug development surging, while TB research moves forward much too slowly; Faster research, approval, and access demanded.

Read More →

Page 10 of 12 · Total posts: 10

←First 9 10 11 Last→